Next Quarterly Earnings
Tuesday, August 11, 2026
CW 33
Pre-Market
In 37 days
Madrigal Pharmaceuticals is a US-based biopharmaceutical company dedicated to the research and development of innovative medicines. The company advances the clinical development of novel therapies to address the unmet medical needs of patients globally. It is committed to pioneering drug development.